AVADEL PHARMACEUTICALS PLC Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q1 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Avadel Pharmaceuticals Plc quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q1 2019 to Q4 2023.
  • Avadel Pharmaceuticals Plc Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending December 31, 2023 was $420K, a 352% increase year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $420K +$327K +352% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $93K -$107K -53.5% Dec 31, 2022 10-K 2023-03-29
Q4 2021 $200K -$76K -27.5% Dec 31, 2021 10-K 2022-03-16
Q4 2020 $276K -$124K -31% Dec 31, 2020 10-K 2021-03-09
Q4 2019 $400K Dec 31, 2019 10-K 2020-03-16
Q3 2019 $513K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $616K Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $677K Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.